secwatch / observer
8-K filed March 5, 2024, 6:59 PM ET CIK 0001162461
other material confidence high sentiment negative materiality 0.65

Cutera settles with Jabil for $19.5M; terminates ZO Skin Health Japan distribution

CUTERA INC

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

CUTERA INC terminated Manufacturing Service Agreement with Jabil Inc..

Action
termination
Agreement
supply
Counterparty
Jabil Inc.
Exact text from the filing
In November 2023, Cutera, Inc. (the “Company”) communicated its intention not to renew its existing manufacturing service agreement (the “Manufacturing Service Agreement”) with Jabil Inc.
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

CUTERA INC entered into Business Transfer and Termination Agreement with ZO Skin Health, Inc. and its affiliates valued at $5.75 million (effective 2024-02-28).

Action
entry
Counterparty
ZO Skin Health, Inc. and its affiliates
Value
$5.75 million
Effective
2024-02-28
Exact text from the filing
On February 28, 2024, the Company and its Japanese subsidiary, Cutera KK, entered into a Business Transfer and Termination Agreement (the “Termination Agreement”) with ZO and its Japanese subsidiary, ZO Skin Health GK
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

CUTERA INC entered into Settlement Agreement with Jabil Inc. valued at $19.5 million (effective 2024-02-28).

Action
entry
Agreement
settlement
Counterparty
Jabil Inc.
Value
$19.5 million
Effective
2024-02-28
Exact text from the filing
On February 28, 2024, the Company and Jabil entered into a settlement agreement related to the non-renewal of the Manufacturing Service Agreement (the “Settlement Agreement”).
View on SEC.gov

737 material agreements filed in the last 30 days. Browse all material agreements →

Source: SEC EDGAR
accession 0001628280-24-008901
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.